Autophagy blockade reduces HER2 levels, mainly on the surface of tumor cells, and FIP200 ablation reduces HER2 levels in tumor cells, resulting in a reduction in the occurrence and progression of HER2-related breast tumors. The gene discussed is ERBB2; the disease is breast neoplasm.